The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
But for all the noise, many Wall Street professionals believe the policy risk in the healthcare sector is lower than feared. ...
Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...
A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback